GeoVax Labs, Inc.
GOVX
$0.40
$0.037.77%
NASDAQ
| 09/30/2025 | 06/30/2025 | 12/31/2024 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | 14.44% | 14.44% | 22.40% |
| Gross Profit | -- | -- | 4.64% | 4.64% | -5.47% |
| SG&A Expenses | -- | -- | -10.58% | -10.58% | -15.21% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -- | 8.81% | 8.81% | 12.88% |
| Operating Income | -- | -- | 5.98% | 5.98% | -0.23% |
| Income Before Tax | -- | -- | 3.75% | 3.75% | -2.37% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -- | -- | 3.75% | 3.75% | -2.37% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -- | 3.75% | 3.75% | -2.37% |
| EBIT | -- | -- | 5.98% | 5.98% | -0.23% |
| EBITDA | -- | -- | 6.07% | 6.07% | -0.11% |
| EPS Basic | -- | -- | 57.55% | 57.55% | 33.76% |
| Normalized Basic EPS | -- | -- | 57.55% | 57.55% | 33.76% |
| EPS Diluted | -- | -- | 57.55% | 57.55% | 33.76% |
| Normalized Diluted EPS | -- | -- | 57.55% | 57.55% | 33.76% |
| Average Basic Shares Outstanding | -- | -- | 196.46% | 196.46% | 94.02% |
| Average Diluted Shares Outstanding | -- | -- | 196.46% | 196.46% | 94.02% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |